Cherry Hill, NJ, United States of America

Phillip Chan

USPTO Granted Patents = 19 

 

Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents

Title: Phillip Chan: Innovator in Biocompatible Polymer Technologies

Introduction: Phillip Chan, based in Cherry Hill, NJ, is a prolific inventor recognized for his significant contributions to polymer technologies and biocompatibility. With an impressive portfolio of 19 patents, Chan has dedicated his career to the development of innovative solutions aimed at reducing contamination in biological substances.

Latest Patents: Among his latest inventions, Chan's patents include groundbreaking methods of using polymers designed to mitigate contamination from toxins. One notable patent details materials and methodologies that involve contacting biological substances with a sorbent capable of adsorbing toxins. This sorbent features a pore structure ranging from 50 Å to 40,000 Å and is engineered to optimize toxin removal. Additionally, he has developed kits that enhance the efficacy of this process by providing a sorbent along with a storage vessel and suitable packaging. Another significant patent focuses on a multi-functional hemocompatible porous bead sorbent, which efficiently removes protein-based toxins and potassium from biological fluids. This invention utilizes biocompatible polymer systems that can adsorb a wide range of protein-based toxins and positively charged ions, showcasing his commitment to advancing medical biotechnology.

Career Highlights: Phillip Chan is currently associated with Cytosorbents Corporation, a company renowned for its innovative therapies in the field of critical care. His work in the company has been pivotal in driving advancements in medical technologies that address urgent health challenges. His patented inventions reflect a deep understanding of polymer chemistry and its applications in real-world medical scenarios.

Collaborations: Throughout his career, Chan has collaborated with esteemed colleagues including Thomas D. Golobish and Vincent J. Capponi. These collaborations have facilitated the exchange of expertise and fostered innovative approaches in their research.

Conclusion: Phillip Chan stands out as a notable inventor whose work has the potential to greatly impact the field of medical biotechnology. His diverse portfolio of patents reflects a commitment to innovation and a passion for problem-solving in health-related applications. As he continues to contribute to the advancement of biocompatible materials, Chan's innovations promise to enhance patient care and environmental safety.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…